Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

Access to medicines latest research on Access to Generics is an important tool to help build a picture of areas where generics companies can continue improving and where investors can focus their engagement to drive better health and business outcomes, raising the bar for what affordable and accessible medicine means worldwide.

Learn more here

Phone:
Finance: 01234 388845
Events: 0330 223 6152

Email:
Event enquiries
Finance enquiries
General enquiries
Membership enquiries
Press enquiries
Training enquiries

Address:
11 Phillips Close
Headley
Hampshire
GU35 8LY

Pensions for Purpose acts as an information centre only. We do not endorse any content published on this website that originated from one of our members. For more information, please see the website terms of use

Sign up to our newsletters

Sign up to receive email updates, including newsletters, event invitations, research briefings, and policy or community news. You can update your preferences at any time.

Email address

First name

Last name

Company name

Required fields

We handle your data with care. See our privacy policies for full details.

Website Terms | Acceptable Use Policy and Content Rules | Privacy and Cookies Policy

Why investors should care about Access to Medicines – Stewart Investors

Find out more about Access to medicines research on Access to Generics and what it means for investors.

Only members with restricted access (ie. academics, asset owners, government and regulatory, independent advisers/trustees and sponsoring employers) can view this article. Please login or join to view.

Sign up to our newsletters